Obicetrapib plus ezetimibe as an adjunct to high-intensity statin therapy: A randomized phase 2 trial
Ballantyne, Christie M., Ditmarsch, Marc, Kastelein, John JP, Nelson, Adam J., Kling, Douglas, Hsieh, Andrew, Curcio, Danielle L., Maki, Kevin C., Davidson, Michael H., Nicholls, Stephen J.
Published in Journal of clinical lipidology (01.07.2023)
Published in Journal of clinical lipidology (01.07.2023)
Get full text
Journal Article
Lipid lowering effects of the CETP inhibitor obicetrapib in combination with high-intensity statins: a randomized phase 2 trial
Nicholls, Stephen J, Ditmarsch, Marc, Kastelein, John J, Rigby, Scott P, Kling, Douglas, Curcio, Danielle L, Alp, Nicholas John, Davidson, Michael H
Published in Nature medicine (01.08.2022)
Published in Nature medicine (01.08.2022)
Get full text
Journal Article
A HIGHLY BIOAVAILABLE OMEGA-3 FREE-FATTY ACID REDUCES NON-HIGH DENSITY LIPOPROTEIN CHOLESTEROL IN HIGH-RISK PATIENTS TREATED WITH A STATIN AND RESIDUAL HYPERTRIGLYCERIDEMIA (ESPRIT TRIAL)
Maki, Kevin C, Orloff, David, Nicholls, Stephen, Dunbar, Richard, Roth, Eli, Curcio, Danielle L, Johnson, Judith, Kling, Douglas F, Davidson, Michael H
Published in Journal of the American College of Cardiology (12.03.2013)
Published in Journal of the American College of Cardiology (12.03.2013)
Get full text
Journal Article